Compare · ATEC vs MDLN
ATEC vs MDLN
Side-by-side comparison of Alphatec Holdings Inc. (ATEC) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATEC and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $53.91B, about 36.6x ATEC ($1.47B).
- Over the past year, ATEC is down 10.7% and MDLN is up 0.2% - MDLN leads by 11.0 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 1 for ATEC).
- MDLN has more recent analyst coverage (25 ratings vs 18 for ATEC).
- Company
- Alphatec Holdings Inc.
- Medline Inc.
- Price
- $9.74+1.62%
- $40.85-0.45%
- Market cap
- $1.47B
- $53.91B
- 1M return
- +20.01%
- +11.83%
- 1Y return
- -10.72%
- +0.25%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2006
- 2025
- News (4w)
- 1
- 4
- Recent ratings
- 18
- 25
Alphatec Holdings Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.
Latest ATEC
- BMO Capital Markets initiated coverage on Alphatec with a new price target
- Director Mcginnis Karen K was granted 32,012 shares and sold $48,460 worth of shares (6,050 units at $8.01) as part of a pre-agreed trading plan, increasing direct ownership by 38% to 94,671 units (SEC Form 4) to cover withholding tax
- Director Blackford Quentin S. was granted 32,012 shares, increasing direct ownership by 6% to 600,381 units (SEC Form 4)
- Director Valentine Keith was granted 32,012 shares, increasing direct ownership by 14% to 264,283 units (SEC Form 4)
- Director Pelizzon David R was granted 32,012 shares, increasing direct ownership by 9% to 378,839 units (SEC Form 4)
- Director Berkowitz Mortimer Iii was granted 32,012 shares, increasing direct ownership by 5% to 650,062 units (SEC Form 4)
- Director Demski David M was granted 32,012 shares, increasing direct ownership by 8% to 431,635 units (SEC Form 4)
- SEC Form S-8 filed by Alphatec Holdings Inc.
- SEC Form 144 filed by Alphatec Holdings Inc.
- SEC Form SD filed by Alphatec Holdings Inc.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)